13. Brealey D, Brand M, Hargreav I, et al.Association between mitochondrial dysfunction and severity and outcome of septic shock.Lancet, 2002, 7:219-223.
[10]
4. Rittirsch D, Huber-Lang MS, Flierl MA, et al.Immunodesign of experimental sepsis by cecal ligation and puncture.Nat Protoc, 2009, 4:31-36.
[11]
5. Levy MM, Fink MP, Marshall JC, et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med, 2003, 31:1250-1256.
[12]
6. Levy RJ.Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis.Shock, 2007, 28:24-28.
[13]
3. Rocha M, Herance R, Rovira S, et al.Mitochondrial dysfunction and antioxidant therapy in sepsis.Infect Disord Drug Targets, 2012, 12:161-178.
